Development of an LC-MS/MS method for the simultaneous determination of 25 benzodiazepines and zolpidem in oral fluid and its application to authentic samples from regular drug users

Journal of Pharmaceutical and Biomedical Analysis

Volumn 74, Issue , 2013, Pages 213-222

  Jang, Moonhee ^a   Chang, Hyejin ^a   Yang, Wonkyung ^a   Choi, Hyeyoung ^a   Kim, Eunmi ^a   Yu, Bum Hee ^b   Oh, Yunhye ^b   Chung, Heesun ^a  

^a National Forensic Service   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Benzodiazepines; Liquid chromatography tandem mass spectrometry; Oral fluid; Zolpidem

Indexed keywords

7 AMINO 1,3 DIHYDRO 5 PHENYL 2H 1,4 BENZODIAZEPIN 2 ONE; 7 AMINOCLONAZEPAM; 7 AMINOFLUNITRAZEPAM; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CHLORDIAZEPOXIDE; CLOBAZAM; CLONAZEPAM; DEALKYLFLURAZEPAM; DIAZEPAM; DRUG METABOLITE; ESTAZOLAM; FLUNITRAZEPAM; FLURAZEPAM; HYDROXYALPRAZOLAM; HYDROXYMIDAZOLAM; HYDROXYTRIAZOLAM; LORAZEPAM; LORMETAZEPAM; MIDAZOLAM; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; PRAZEPAM; TEMAZEPAM; TRIAZOLAM; UNCLASSIFIED DRUG; ZOLPIDEM;

ACCURACY; ARTICLE; BODY FLUID; DRUG DETERMINATION; DRUG USE; FORENSIC TOXICOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; ORAL FLUID; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

BENZODIAZEPINES; CHROMATOGRAPHY, LIQUID; HUMANS; MENTAL DISORDERS; MOUTH; PYRIDINES; REPRODUCIBILITY OF RESULTS; SALIVA; TANDEM MASS SPECTROMETRY;

EID: 84871811202     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.11.002     Document Type: Article

References (30)

1. Fraser A.D. Use and abuse of the benzodiazepines. Ther. Drug Monit. 1998, 20:481-489.
2. George P., Rossey G., Depoortere H., Mompon B., Allen J., Wick A. Zolpidem and related compounds: syntheses, physical properties and structure-activity relationships. Imidazopyridines in Sleep Disorders 1988, 11-23. Raven Press, New York. J.P. Sauvanet, S.Z. Langer, P.L. Morselli (Eds.).
3. Drummer O.H. The Forensic Pharmacology of Drugs of Abuse 2001, Hodder Arnold, London. 1st ed.
4. Maurer H.H. Mass spectrometric approaches in impaired driving toxicology. Anal. Bioanal. Chem. 2009, 393:97-107.
5. Bosker W.M., Huestis M.A. Oral fluid testing for drugs of abuse. Clin. Chem. 2009, 55:1910-1931.
6. Vindenes V., Lund H.M.E., Andresen W., Gjerde H., Ikdahl S.E., Christophersen A.S., Øiestad E.L. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci Int. 2012, 219:165-171.
7. Gallardo E., Queiroz J.A. The role of alternative specimens in toxicological analysis. Biomed. Chromatogr. 2008, 22:795-821.
8. Cone E.J., Clarke J., Tsanaclis L. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. J. Anal. Toxicol. 2007, 31:424-433.
9. Pehrsson A., Gunnar T., Engblom C., Seppä H., Jama A., Lillsunde P. Roadside oral fluid testing: comparison of the results of Drugwipe 5 and Drugwipe Benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci. Int. 2008, 175:140-148.
10. Concheiro M., De Castro A., Quintela Ó., Cruz A., López-Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2008, 391:2329-2338.
11. Badawi N., Simonsen K.W., Steentoft A., Bernhoft I.M., Linnet K. Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS. Clin. Chem. 2009, 55:2004-2018.
12. Quintela O., Crouch D.J., Andrenyak D.M. Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device. J. Anal. Toxicol. 2006, 30:614-616.
13. Moore C., Coulter C., Crompton K., Zumwalt M. Determination of benzodiazepines in oral fluid using LC-MS-MS. J. Anal. Toxicol. 2007, 31:596-600.
14. Langel K., Engblom C., Pehrsson A., Gunnar T., Ariniemi K., Lillsunde P. Drug testing in oral fluid-evaluation of sample collection devices. J. Anal. Toxicol. 2008, 32:393-401.
15. Peters F.T., Drummer O.H., Musshoff F. Validation of new methods. Forensic Sci. Int. 2007, 165:216-224.
16. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
17. Viswanathan C.T., Bansal S., Booth B., DeStefano A.J., Rose M.J., Sailstad J., Shah V.P., Skelly J.P., Swann P.G., Weiner R. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 2007, 9:E30-E42.
18. Remane D., Meyer M.R., Wissenbach D.K., Maurer H.H. Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs. Anal. Bioanal. Chem. 2011, 401:1341-1352.
19. Samyn N., De Boeck G., Cirimele V., Verstraete A., Kintz P. Detection of flunitrazepam and 7-aminoflunitrazepam in oral fluid after controlled administration of rohypnol. J. Anal. Toxicol. 2002, 26:211-215.
20. Hart B.J., Wilting J., de Gier J.J. The stability of benzodiazepines in saliva. Methods Find. Exp. Clin. Pharmacol. 1988, 10:21-26.
21. Kempf J., Wuske T., Schubert R., Weinmann W. Pre-analytical stability of selected benzodiazepines on a polymeric oral fluid sampling device. Forensic Sci. Int. 2009, 186:81-85.
22. Drummer O.H. Drug testing in oral fluid. Clin. Biochem. Rev. 2006, 27:147-159.
23. Kintz P., Villain M., Cirimele V., Pépin G., Ludes B. Windows of detection of lorazepam in urine, oral fluid and hair, with a special focus on drug-facilitated crimes. Forensic Sci. Int. 2004, 145:131-135.
24. Drummer O.H. Review: Pharmacokinetics of illicit drugs in oral fluid. Forensic Sci. Int. 2005, 150:133-142.
25. Crouch D.J. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci. Int. 2005, 150:165-173.
26. Cone E.J., Huestis M.A. Interpretation of oral fluid tests for drugs of abuse. Ann. N. Y. Acad. Sci. 2007, 1098:51-103.
27. Ngwa G., Fritch D., Blum K., Newland G. Simultaneous analysis of 14 benzodiazepines in oral fluid by solid-phase extraction and LC-MS-MS. J. Anal. Toxicol. 2007, 31:369-376.
28. Heltsley R., DePriest A., Blank D.L., Robert T., Marshall L., Meadors V.M., Caplan Y.H., Cone E.J. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. J. Anal. Toxicol. 2011, 35:529-540.
29. Aps J.K., Martens L.C. Review: The physiology of saliva and transfer of drugs into saliva. Forensic Sci. Int. 2005, 150:119-131.
30. Kujirai M., Sawaki K., Kawaguchi M. Inhibitory effect of diazepam on muscarinic receptor-stimulated inositol 1 4,5-trisphosphate production in rat parotid acinar cells. Br. J. Pharmacol. 2002, 137:945-952.